Scores by kind of claim
Each kind of claim is scored on its own, out of 100: the share that held up, with the range it likely falls in. Fewer resolved claims give a wider range.
-
Factual claims
Statements about the present or the past, checked against the record: did they hold up?
83 77 88 -
Predictions
Statements about events outside the person's control, checked once they fell due: did they come true?
69 49 87 -
Promises
Commitments to the person's or organisation's own future action, with something to deliver: was it delivered?
69 49 87
All types combined: 81 (likely 76 to 86, high confidence), from 87 claims: 77 factual claims, 5 predictions, 5 promises. It mixes kinds of claim in different proportions for different people, so compare people kind by kind.
Sam Altman's claims
41 claims
“Delighted to finally invest in @TrialSpark:”
Sam Altman, investor, on X 30 September 2021 Post by @sama on X, 2021-09-30 (X)
Sam Altman invested in TrialSpark, announced on 2021-09-30.
Resolved true The record shows it happened or was so.
What would count as true or false
True: a dated record shows that Altman personally invested in TrialSpark and announced it on or around 2021-09-30, for example a tweet from him on that date, or a TrialSpark funding announcement listing him as an investor. Mostly true: he invested, but the announcement date is off by a few days, or the investment was made through a vehicle he controls. Mixed: the evidence shows only a related tie, such as investment through a fund he does not control, or an advisory role. Mostly false: there is only an expressed intent to invest, with no completed investment. False: records show he was not an investor in TrialSpark.
Evidence
- TrialSpark raises $156MM Series C Funding led by Sam Altman and Lachy Groom PRNewswire (issued by TrialSpark) · 30 September 2021
“TrialSpark announced today that it has raised $156MM in Series C funding. Sam Altman and Lachy Groom led the round, with participation from new and existing investors, including Sequoia Capital”
- Fenwick Represents TrialSpark in $156M Series C Financing | Fenwick Fenwick & West LLP · 30 September 2021
“Fenwick represented TrialSpark, a technology-driven pharma company that runs end-to-end clinical trials, in its $156 million Series C financing. The round was led by Sam Altman and Lachy Groom”
- TrialSpark Venture Capital and Private Equity Financings VC News Daily (Massinvestor, Inc.)
“09/30/21 | $156,000,000 | Series C | ArrowMark Partners<br>Casdin Capital<br>Dragoneer Investment Group<br>Felicis Ventures<br>John Doerr<br>Lachy Groom<br>Sam Altman”
- Where OpenAI CEO Sam Altman invests Leadpanda · 28 September 2024
“Altman invested in the company in a Series B round in October 2018 and a Series C round in September 2021.”
Reasoning
TrialSpark's press release dated 2021-09-30 [E1] says it raised a $156MM Series C round led by Sam Altman and Lachy Groom. Fenwick's deal note from the same date [E2] says the same, and the VC News Daily funding database [E3] lists Sam Altman among the investors in the Series C dated 09/30/21. Together these meet the true criterion: a dated funding announcement names Altman personally as an investor on that date.
Cite this claim
Sam Altman, “Sam Altman invested in TrialSpark, announced on 2021-09-30.” (said 30 September 2021). Verdict: resolved true. Reliability API, claim c_e79e6c785e24, method 0.1.0+c876030c. https://epistacklabs.com/claims/c_e79e6c785e24
Claims without a verdict
Is a verdict here wrong, or do you speak for Sam Altman? Reply on the claim's own page, with the form at its foot (how replies work). Verdicts are made automatically; how verdicts and scores are made.